AB&B BIO-TECH-B(02627) has been included in the Hang Seng Index.

date
08:26 16/02/2026
avatar
GMT Eight
Zhonghui Biotechnology-B (02627) announces that the company's H-shares have been selected and will be included in the Hang Seng Composite Index starting from March 9, 2026. The Hang Seng Composite Index is a comprehensive H-share index that covers the top 95% of companies listed on the main board of the Hong Kong Stock Exchange by market capitalization, and is widely used by index funds, mutual funds, and performance evaluation systems.
AB&B BIO-TECH-B (02627) announced that its H shares have been selected and will be included in the Hang Seng Composite Index, effective from March 9, 2026. The Hang Seng Composite Index, as a comprehensive H share index, covers the top 95% of companies listed on the HKEX main board by market capitalization, and is widely used by index funds, mutual funds, and performance evaluation systems. The board of directors believes that the company's inclusion in the Hang Seng Composite Index reflects the capital market's recognition of the company's business performance and growth prospects. The board of directors is confident that this inclusion will help expand the company's shareholder base, enhance the trading liquidity of H shares, and further strengthen the company's reputation and brand awareness.